Upcoming Webinars

An Investigation into Integration of Disposable Components into Traditional Stainless-steel Facilities

Presented by Ron Bates, Bristol-Myers Squibb and Miriam Monge, Sartorius Stedim biotech Integrated Solutions
22nd May 2018


Environmental Monitoring Trend Analysis Tools

Presented by Steve Walton, Technical Manager in Sterility Assurance with Sanofi Pasteur, Toronto
23rd May 2018


Current USP Perspectives on a Rapid Sterility Test

Presented by Presented by Dr David Roesti, Novartis/USP
30th May 2018


Extractable Study Design and Data Evaluation of Polymeric Product Contact Materials

Presented by Dr. Ping Wang, Principal Scientist, Janssen R&D and Dr Nixdorf, SGS Group
05th June 2018


Finding the Common Road to Quality for Single Use Materials

Presented by Dr Trishna Ray-Chaudhuri, Genentech and Dr Hélène Pora & Dr James Hathcock of Pall Biotech
06th June 2018


Preview of USP’s Informational Chapter <1085>, “Guidelines on the Endotoxins Test”

Presented by Karen Zink McCullough & Kevin L. Williams
11th June 2018


Fully continuous biosimilar manufacturing framework: A case study

Presented by Samir Varma, Head of Manufacturing, Enzene Biosciences
14th June 2018


Manufacturing strategies for Biosimilar: A case of continuous capture

Presented by Solomon Alva, Antibody Purification Group Lead, Senior Scientific Manager, Biocon Research Limited
15th June 2018


mAb Industry in China : Biosimilars vs Innovative Biologics

Presented by Dr. Joe X Zhou, CEO, Genor Biopharma, Walvax Bio Group and Floris De Smet, Sartorius Stedim Biotech
18th June 2018


Platform technology development for biosimilar upscaling

Presented by Dr H. Fai Poon, President, QuaCell Biotech Ltd and Floris De Smet, Sartorius Stedim Biotech
21st June 2018


Challenges in the Development of Continuous Processes for Vaccines

Presented by Danny Vellom of Sanofi Pasteur Biologics, Inc.
27th June 2018


Strategies to overcome Low Endotoxin Recovery using the conventional LAL assay

Presented by Dr. Ruth Daniels, Janssen & Kevin L. Williams, BIOMÉRIEUX
28th June 2018


Raman spectroscopy measurements during Bioprocessing

Presented by Nobel Vale, Research Scientist II, Bristol-Myers Squibb
11th July 2018


Development and Manufacturing of Recombinant Nanoparticle Vaccines

Presented by Atin Tomar, President & CEO, CPL Biologicals Pvt. Ltd and Stefan Schlack, Senior Vice President of Marketing & Product Management, Sartorius Stedim Biotech
12th July 2018


Key components of a comprehensive program for the management of single use technologies in biologics manufacturing

Presented by John Maguire, Shire and Donald Young, ThermoFisher Scientific
18th July 2018


Quality-By-Design in Spray Drying Processes – Transfer Lab to Production

Presented by Sune Klint Andersen and Filipe Gaspar, Hovione FarmaCiência
25th July 2018


Lifecycle management of single use technologies

Presented by Francis Verhoeye, Director Single Use Technologies, GSK Vaccines
25th July 2018


Subvisible Particles Matter, Developments in Regulations and Low Volume Methods

Presented by Dr Satish K Singh, Lonza
26th July 2018


Next generation processes: What model works the best in Asia?

Presented by Ravishankar Kasturi, Vice President, Head of Manufacturing & Process Development, Reliance Life Sciences
09th August 2018


Mixed mode Chromatography in Purifying biologics – Overview

Presented by Vivek Halan, Senior Scientific manager, Zumutor Biologics Pvt Ltd
13th August 2018


Is India Anywhere Closer to Implementing Continuous Bioprocessing

Presented by Narasimha Rao Nedunuri, Managing Director of CLONZ
16th August 2018


Implementing CMC Strategies for scale-up operations in biologics manufacturing

Presented by Dr Anita Krishnan, Principal Scientist Lupin Ltd
20th August 2018


Material Understanding for Continuous Manufacturing of Solid Dosage Forms

Presented by Dr Yifan Wang, Regulatory Research Scientist, FDA CDER
23rd August 2018


Project and Portfolio Management as a key tool to manage continuous improvement in bio-pharma manufacturing

Presented by Gloria Gadea-Lopez, Ph.D.and Melvin Santos, Shire
06th September 2018


Efficiency by Design – Case Study for a Hybrid Clinical Manufacturing Facility

Presented by Dr Sourav Kundu, Senior Director, Process Development and Clinical manufacturing, Teva Pharmaceuticals
12th September 2018


Advanced process development using automated micro bioreactors shortens timelines and provides process solutions for a rapid scale up

Presented by Dr. Jincai Li, Vice President of WuXi Biologics
14th September 2018


DSF and FTIR as complementary methods for the identification and characterization of vaccine products

Presented by Marina Kirkitadze, Deputy Director, Head of Biophysics & Conformation Unit, Analytical R&D Biochemistry, Sanofi Pasteur and Rina Dukor, President, BioTools
18th September 2018


Developability Assessment of Therapeutic Proteins – A Toolbox for Tackling Increasing Complexity

Presented by Thorsten Lorenz, Team Head Developability Assessment Biologics, Novartis
27th September 2018


Impact of Depth Filtration on Disulfide Bond Reduction during Downstream Processing of Monoclonal Antibodies from CHO Cell Cultures

Presented by Brian O'mara, Senior Research Scientist I, Bristol-Myers Squibb
08th October 2018


Extractables and leachables testing using a Quality Risk Management approach

Presented by Dhaval Tapiawala, Principal Scientist, Pfizer
17th October 2018


Application of Multivariate Data Analysis for Process Diagnostic and Root Cause Analysis

Presented by Ramila Peiris, Ph.D., Manager, Process Modelling and Process Analytical Technology, Sanofi Pasteur
23rd October 2018


Advances and Challenges in Vaccine Development and Manufacture

Presented by Tony D'Amore, Vice Preseident, Product Research & Development, Sanofi Pasteur
02nd November 2018


Regulatory Approval of Three Rapid Microbiological Methods for MACI Product Release

Presented by John Duguid
08th November 2018


Evolve Manufacturing Processes by Implementing Disruptive Technologies

Presented by Presented by Yuyi Shen, Principal Scientist, Grifols
19th November 2018


Reducing Microbiological Risk and Using Quality Tools in the Pharmaceutical Industry

Presented by Don Singer
09th January 2019